Dividends Calendar Earnings Calendar
XFOR

XFOR | X4 Pharmaceuticals, Inc

X4 Pharmaceuticals, Inc
  • Industry: Biotechnology

Quick infos

    Trade prices

    • Volume:
    • Market Cap: 32.06M
    • Prev closed:
    • Open:
    • High:
    • Low:
    • 52 week low:
    • 52 week high:
    • Dividends:No Dividends

    Next ER: August 4, 2022  Before Market Opens



    Top Stories (XFOR)

      Company Profile

      X4 is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases. X4?s pipeline is comprised of first-in-class, oral, small molecule antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies, neutropenia, and certain cancers.

      Earnings History

      Date EPS / Forecast Revenue / Forecast
      November 10, 2022
      August 4, 2022-0.6 / -0.6317- / -
      May 12, 2022-0.72 / -0.6014- / -
      March 17, 2022-1.24 / -0.6743- / -
      November 4, 2021-0.76 / -0.715- / -
      view more

      Historical Data

      DatePriceOpenHighLowVolChangeER
      Aug 4, 2022 1.270 1.260
      1.318
      1.260
      130.30K -1.55%
      Aug 3, 2022 1.290 1.270
      1.330
      1.250
      258.42K 10.26%
      Aug 2, 2022 1.170 1.320
      1.320
      1.150
      191.77K -10%
      Aug 1, 2022 1.300 1.270
      1.380
      1.250
      598.42K 1.56%
      Jul 29, 2022 1.280 1.300
      1.300
      1.212
      97.64K -1.54%
      Jul 28, 2022 1.300 1.200
      1.500
      1.180
      470.36K 10.17%
      Jul 27, 2022 1.180 1.140
      1.217
      1.134
      62.37K 0%
      Jul 26, 2022 1.180 1.200
      1.205
      1.100
      138.33K -1.67%
      Jul 25, 2022 1.200 1.160
      1.300
      1.151
      219.24K 0.84%
      Jul 22, 2022 1.190 1.190
      1.337
      1.160
      216.91K -4.8%
      view more
      SPNV

      News

      News for (XFOR)

      This company doesn't provide a dividend.


      Talk about X4 Pharmaceuticals, Inc below in comments section below.

      Do you think you'll buy? Do you already have active trades now?

      EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
      This profile is based on publicly available information and is intended to be informative in nature.

      Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




      Other ER on Aug 4, 2022 (Same day)

      ntdoy baba cx syna tm gpro newr clls trip w z swks 


      Jump to (Finance sites)

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      Technical Analysis For Dummies
      Buy on Amazon

      Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

      A simple, straightforward guide to the fundamentals of technical analysis